Examining patient outcomes of receiving long-acting injectable antipsychotics.
The purpose of this project was to evaluate a long-acting injectable (LAI) antipsychotics program regarding the quality of care and outcomes of individuals with schizophrenia. Observational design with retrospective chart review and survey was utilized in an outpatient clinic. Individuals on LAIs receive the quality of care by exhibiting favorable knowledge about LAIs, positive attitude toward medications, and satisfaction with care. They take higher dosages of medications than those who take oral antipsychotics and report decreases in hospitalizations/emergency room visits after LAIs. Reducing reservations about LAIs may provide awareness of the positive effects of treatment leading to viable management options and patient satisfaction.